Alladapt Immunotherapeutics

About Alladapt Immunotherapeutics

Alladapt is a biotechnology startup that operates in the healthcare sector, specifically focusing on the development of prescription therapeutics for the treatment of food allergies. The company's mission is to create a single therapeutic solution that can manage a wide range of common food allergies, such as cow’s milk, eggs, tree nuts, peanuts, shellfish, and sesame. This is a significant market, with over 6 million children and 26 million adults in the United States alone suffering from food allergies.

Alladapt's business model revolves around leveraging the growing body of knowledge on the underlying biology of food allergies. Their team of industry-leading scientists and biotechnology professionals are working to develop a solution that can help the human immune system adapt to nearly all food allergens, a process known as oral immunotherapy.

The company's primary revenue stream is expected to come from the sale of these prescription therapeutics once they are developed and approved for use. Given the large number of people affected by food allergies, the potential market for their product is substantial.

Alladapt's goal is not just to treat food allergies, but to improve the quality of life for those affected by them. The company aims to reduce the fear and anxiety associated with food allergies, allowing patients to experience more of life's magical moments with greater confidence.